Disable ads (and more) with a membership for a one time $4.99 payment
Quinupristin/Dalfopristin is approved for the treatment of?
Hepatic encephalopathy
Complicated skin and soft-tissue infections (SSTI)
Bloodstream infections
Common cold
The correct answer is: Complicated skin and soft-tissue infections (SSTI)
Quinupristin/Dalfopristin, also known as Synercid, is a combination antibiotic that is used specifically for the treatment of complicated skin and soft-tissue infections (SSTI). These types of infections are often caused by drug-resistant bacteria and require a strong and targeted antibiotic like Quinupristin/Dalfopristin. This medication is not approved for the treatment of hepatic encephalopathy, bloodstream infections, or the common cold. Therefore, options A, C, and D are incorrect.